急性呼吸衰竭无创通气患者呼吸困难:患病率、危险因素与预后影响
本研究基于法国和比利时54个ICU的前瞻性观察队列二次分析,纳入426例因急性呼吸衰竭接受无创通气的患者,用改良Borg量表测量呼吸困难。首次无创通气后呼吸困难评分≥4与无创通气失败(OR 2.41,p=0.001)和死亡率(OR 2.11,p=0.009)独立相关。
要点
- 因急性呼吸衰竭接受无创通气的患者中,呼吸困难常见且强度较高。
- 首次无创通气后Borg评分≥4与无创通气失败和死亡风险独立相关。
- 焦虑、漏气、高呼吸频率和SOFA评分与呼吸困难强度≥4相关。
核心结论
- 因急性呼吸衰竭接受无创通气的患者呼吸困难常见且强烈,并与无创通气失败和较差预后相关。
研究设计与样本
- 基于法国和比利时54个ICU的前瞻性观察队列研究的二次分析,纳入426例因急性呼吸衰竭接受无创通气的患者。
- 呼吸困难采用改良Borg量表测量。
主要发现
- 入ICU时呼吸困难评分中位数(四分位距)为4(3-5),首次无创通气后为3(2-4),p=0.001。
- 首次无创通气后呼吸困难强度≥4与SOFA评分(OR 1.12,p=0.001)、呼吸频率(OR 1.03,p=0.032)、焦虑(OR 1.92,p=0.006)、漏气(OR 2.5,p=0.002)和动脉二氧化碳分压(OR 0.98,p=0.025)相关。
- 呼吸困难强度≥4独立关联无创通气失败(OR 2.41,p=0.001)和死亡率(OR 2.11,p=0.009),但与ICU后负担增加和生活质量改变无关。
临床怎么用
- 对因急性呼吸衰竭接受无创通气的患者应评估呼吸困难强度,识别高风险患者。
- 针对焦虑、漏气和高呼吸频率等可干预因素可能有助于改善预后。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Dyspnoea is a frequent and intense symptom in intubated patients, but little attention has been paid to dyspnoea during noninvasive mechanical ventilation in the intensive care unit (ICU).The objectives of this study were to quantify the prevalence, intensity and prognostic impact of dyspnoea in patients receiving noninvasive ventilation (NIV) for acute respiratory failure (ARF) based on secondary analysis of a prospective observational cohort study in patients who received ventilatory support for ARF in 54 ICUs in France and Belgium. Dyspnoea was measured by a modified Borg scale.Among the 426 patients included, the median (interquartile range) dyspnoea score was 4 (3-5) on admission and 3 (2-4) after the first NIV session (p=0.001). Dyspnoea intensity ≥4 after the first NIV session was associated with the Sequential Organ Failure Assessment Score (odds ratio (OR) 1.12, p=0.001), respiratory rate (OR 1.03, p=0.032), anxiety (OR 1.92, p=0.006), leaks (OR 2.5, p=0.002) and arterial carbon dioxide tension (OR 0.98, p=0.025). Dyspnoea intensity ≥4 was independently associated with NIV failure (OR 2.41, p=0.001) and mortality (OR 2.11, p=0.009), but not with higher post-ICU burden and altered quality of life.Dyspnoea is frequent and intense in patients receiving NIV for ARF and is associated with a higher risk of NIV failure and poorer outcome.
引用
- Dangers L, Montlahuc C, Kouatchet A, et al. Dyspnoea in patients receiving noninvasive ventilation for acute respiratory failure: prevalence, risk factors and prognostic impact: A prospective observational study. Eur Respir J. 2018. PMID: 29976650. doi:10.1183/13993003.02637-2017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。